In another study, the authors showed that SLAMF3 plays a role in the differentiation of regulatory T cells, through the enhancement of CD4+ T cells’ sensitivity to IL-2, a cytokine whose availability is reduced in patients with SLE (10). Here, LY9 is linked to systemic lupus erythematosus.